FEB 11, 2021 10:00 AM PST

Intact and peptide level characterization of nanobodies by high resolution HPLC-MS/MS

Sponsored by: SCIEX
Speaker

Abstract
Date:  February 11, 2021
Time: 10:00am (PST),  1:00pm (EST)
 
Nanobodies are single-domain antibodies derived from heavy-chain-only antibodies (HcAbs) commonly found in camelids, consisting solely of the variable, antigen-binding domain. Their small size affords some unique properties such as higher stability, better tissue penetration with potential access to cryptic tumors and easier, higher yield prokaryotic production, which has attracted growing interest in therapeutic and research use.
 
In this work, we characterized the stochastic labeling of two research-grade nanobodies using the benchtop X500B QTOF LC-MS/MS System. The former nanobody contains an Alexa Fluor dye conjugated via the maleimide linker, while the latter nanobody is biotin-labeled via N-hydroxysuccinimide (NHS) conjugation. A quick and reproducible intact mass measurement was able to confirm the ID, purity, modifications and disulfide bonds. The differences in heterogeneity in labeling between maleimide and NHS chemistry is also readily seen. A rapid trypsin digestion followed by peptide mapping was carried out to pinpoint the specific sites and degrees of labeling. Finally, we were able to adjust the biotin labeling efficiency by varying reagent to nanobody ratio . The expression, purification and characterization of these research-grade nanobodies lay the groundwork for future therapeutic programs.
 
Learning Objectives
  • Nanobodies as an alternative to monoclonal IgGs and its unique properties and advantages
  • Facile characterization of nanobodies and their functional derivatives using LC-MS
  • Fine tuning of product properties guided by LC-MS data
 
 
Webinars will be available for unlimited on-demand viewing after live event.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
DEC 09, 2021 6:00 AM PST
C.E. CREDITS
DEC 09, 2021 6:00 AM PST
Date: December 9, 2021 Time: 6:00am (PDT), 9:00 am (EDT) As the number of biotherapeutic candidates in development is increasing, the requirements of analytical tools to understand the molec...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources